Boothbay Fund Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Hold
0
1914
2025
Q3
Sell
-20,000
Closed -$473K 1842
2025
Q2
$431K Buy
+20,000
New +$372K 0.01% 964
2025
Q1
Hold
0
1361
2024
Q4
Sell
-17,157
Closed -$264K 1446
2024
Q3
$264K Buy
+17,157
New +$286K 0.01% 1306
2024
Q2
Hold
0
1481
2024
Q1
Hold
0
1539
2023
Q4
Hold
0
1617
2023
Q3
Hold
0
1686
2023
Q2
Sell
-12,856
Closed -$242K 1739
2023
Q1
$242K Sell
12,856
-45,253
-78% -$862K 0.01% 1630
2022
Q4
$925K Hold
58,109
0.03% 930
2022
Q3
$951K Buy
+58,109
New +$941K 0.03% 901
2021
Q4
Sell
-28,434
Closed -$472K 1815
2021
Q3
$472K Sell
28,434
-7,193
-20% -$139K 0.02% 1120
2021
Q2
$869K Buy
35,627
+18,225
+105% +$411K 0.03% 767
2021
Q1
$449K Buy
17,402
+11,621
+201% +$512K 0.02% 991
2020
Q4
$309K Sell
5,781
-891
-13% -$44.2K 0.02% 939
2020
Q3
$275K Buy
+6,672
New +$288K 0.02% 832
2020
Q2
Hold
0
940
2020
Q1
Hold
0
822
2019
Q4
Hold
0
826
2018
Q4
Sell
-14,893
Closed -$309K 636
2018
Q3
$309K Buy
+14,893
New +$234K 0.04% 496

Other funds holding ACAD